Head-to-head · WeighScore
Cost Plus Drugs vs Sprout Health
By GLP-1 ScorecardUpdated
Score comparison
Sprout Health has the higher recorded score — 79.8/100 to 58.5/100.
Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Cost Plus Drugs | Sprout Health |
|---|---|---|
| WeighScore | 58.5/100 | 79.8/100 |
| Grade | C | C+ |
| Site position | #419 | #26 |
| Semaglutide | $279/mo (brand Ozempic) | $149/4 weeks (main-site offer; confirm selected plan) |
| Tirzepatide | Not disclosed | $199/4 weeks (main-site offer; confirm selected plan) |
| Coverage | All 50 states | State exclusions in terms; confirm current eligibility |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #419 · C
Strengths
- Transparent pricing: wholesale cost + 15% markup + $5 pharmacy fee, the same for everyone
- Around $279/mo for branded Ozempic — well below typical retail list prices
- Mark Cuban's PBM-disrupting pharmacy, praised by Forbes Health, Wired, and KFF Health News
- Ships to all 50 states; genuine FDA-approved Novo Nordisk Ozempic, not compounded
- Partnered with 9amHealth so you can get prescribed and fill at Cost Plus pricing
What to consider
- Fulfillment only — no telehealth intake; you need a prescription from an outside clinician
- Ozempic is FDA-indicated for type 2 diabetes, not weight management — weight-loss use is off-label
- Wegovy availability has been spotty — check current stock before assuming it ships
- No compounded semaglutide or tirzepatide — brand only
- No clinical follow-up — side-effect monitoring falls to your prescribing clinician
Site position #26 · C+
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Strengths
- Main-site compounded injection plans list $149 semaglutide / $199 tirzepatide per four weeks
- Evaluation, medication and shipping advertised as included
- Current policy allows a full refund before pharmacy transmission, including after clinical review
- Terms identify a clinical network and possible pharmacy contacts
What to consider
- The $99/$149 annual equivalents require $1,188/$1,788 upfront; selected offer terms need confirmation
- Four-week billing differs from calendar-month billing, and policy descriptions differ across plan types
- Cancellation requires 48-hour billing notice; shipment pauses need five business days
- Assigned clinician/pharmacy, state eligibility and current branded access remain unconfirmed
- An order becomes nonrefundable after pharmacy transmission; follow FDA guidance for warm injectable shipments
Featured provider
Sprout Health
Sprout Health scores 79.8/100 (C+). Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.